drugset / Trial / NCT01591980

Effects of Perioperative Pregabalin for Post-Craniotomy Pain

NCT01591980 ↗

Phase 4 Withdrawn Unity Health Toronto
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Objective: To compare the incidence of chronic pain at 3 months among adults undergoing craniotomy between those received two different doses of pregabalin and those receiving placebo.

Timeline

Start
2013-08
Primary completion
2014-08
Completion
2014-08

Outcome

Outcome not reported

Stopped: “Pfizer Canada and the SMH ORA could not come into an agreement on responsibility to be the Importer of Record for the trial.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 100 mg —
Subject Pregabalin Small molecule 150 mg —